Why the study?
Does endogenous insulin release differentially affect lipolysis after adrenergic stimulation in obese subjects with versus without type 2 diabetes?
Does endogenous insulin release differentially affect lipolysis after adrenergic stimulation in obese subjects with versus without type 2 diabetes?
Obese subjects with type 2 diabetes exhibit an impaired insulin-induced inhibition of lipolysis following norepinephrine stimulation compared to healthy obese controls.
No takes yet. Share an insight, caveat, or question.
Impaired antilipolysis in T2D may worsen lipid dysregulation; leaves open whether this mechanism warrants targeted interventions.
Schümann et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: